Pap Smear Screening and Determinants in Women With Type 2 Diabetes at a Public Hospital in Guanajuato

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Cervical cancer is a leading cause of cancer-related deaths among Mexican women [75]. Women with type 2 diabetes mellitus are more prone to HPV infections, raising their cervical cancer risk [23]. Despite global guidance for Pap smear screening, coverage is low in this group [30]. This study will assess Pap smear use among women aged 21 to 64 with type 2 diabetes at the HGZC/MF No. 21 clinic in León, Guanajuato, in late 2024. Using random sampling and a cross-sectional design, the study will evaluate sociodemographic and clinical factors through structured interviews, aiming to identify screening coverage gaps and guide early prevention strategies for women with chronic illnesses [33].

Article activity feed